Cash and Cash Equivalents, at Carrying Value of CASI Pharmaceuticals, Inc. from 31 Dec 2021 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
Summary
CASI Pharmaceuticals, Inc. quarterly Cash and Cash Equivalents, at Carrying Value in USD history and change rate from 31 Dec 2021 to 31 Dec 2024.
  • CASI Pharmaceuticals, Inc. Cash and Cash Equivalents, at Carrying Value for the quarter ending 31 Dec 2024 was $13,468,000, a 21% decline year-over-year.
Source SEC data
View on sec.gov
Cash and Cash Equivalents, at Carrying Value, Quarterly (USD)
Cash and Cash Equivalents, at Carrying Value, YoY Quarterly Change (%)

CASI Pharmaceuticals, Inc. Quarterly Cash and Cash Equivalents, at Carrying Value (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $13,468,000 -$3,615,000 -21% 31 Dec 2024 20-F 31 Mar 2025 2024 FY
Q4 2023 $17,083,000 -$30,029,000 -64% 31 Dec 2023 20-F 31 Mar 2025 2024 FY
Q4 2022 $47,112,000 +$8,408,000 +22% 31 Dec 2022 20-F 28 Mar 2024 2023 FY
Q4 2021 $38,704,000 31 Dec 2021 20-F 26 Apr 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.